Robert Baxter
Professor
Medicine
University of Sydney
Australia
Biography
Rob Baxter is head of the Hormones and Cancer laboratories at the Kolling Institute, University of Sydney/Royal North Shore Hospital, where he was formerly the institute director until January 2012. Since then he has concentrated on his research in translational cancer biology and proteomics.
Research Interest
Medicine
Publications
-
Liu, C., Teh, R., Mozar, C., Baxter, R., Rasmussen, H. (2016). Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and y -radiation on Na+/K+-ATPase and cell survival. Breast Cancer Research and Treatment, 155(2), 203-213.
-
Scully, T., Firth, S., Scott, C., de Silva, H., Pintar, J., Chan-Ling, T., Twigg, S., Baxter, R. (2016). Insulin-like growth factor binding protein-3 links obesity and breast cancer progression. Oncotarget, 7(34), 55491-55505
-
Ochnik, A., Baxter, R. (2016). Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer. Endocrine-Related Cancer, 23(11), R527-R550
